* Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ICMJE

Completed

Enrollment ICMJE

69

Completion Date

August 2014

Primary Completion Date

August 2014 (final data collection date for primary outcome measure)

Eligibility Criteria ICMJE

Inclusion Criteria:

Patients with Type 2 Diabetes Mellitus

adults aged ≥ 20 and aged ≤ 70 years old

Patients who had not taken anti diabetes drug for 8 weeks prior to screening visit with HbA1c ≥ 7.5%

All patients give written informed consent

Patients applicable to any one of following 3 categories

Patients with surgically induced infertility

Post-menopause woman ≥45 years of age with over 2 years from the last menstruation

Fertile pre-menopause woman or male patients who has consented for use of two or more contraceptive methods at least up to 14 days after final administration of the investigational product to avoid getting pregnant

Exclusion Criteria:

Patients with Type 1 Diabetes, Patients with Diabetic Ketoacidosis or Diabetic Coma as well as Pre-coma

Patients with Gestational Diabetes Mellitus or with Secondary Diabetes